CME Group Inc. (CME) reported $6.97B of revenue for the twelve months ended Sep 30, 2026. That is up 9.0% from the year before. Revenue for fiscal 2025 was $6.52B.

Yes. CME Group Inc. earned $4.43B in net income for the twelve months ended Sep 30, 2026, a net margin of 63.5%.

How much cash and debt does CME have?

CME Group Inc. reported $2.20B in cash and cash equivalents on its most recent balance sheet in SEC filings.

How fast is CME revenue growing?

CME Group Inc.'s revenue changed +6.4% in fiscal 2025, to $6.52B. Its compound annual growth rate was +6.0% over 5 years and +7.0% over 10 years.

What is CME free cash flow?

CME Group Inc. generated $4.33B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $4.43B less capital expenditures.

What is CME earnings per share?

Diluted earnings per share were $12.19 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did CME last report financial results?

The latest statements here come from CME Group Inc.'s 10-Q filed on Oct 23, 2026, covering the period ended Sep 30, 2026.

Where does this CME financial data come from?

Quantisnow builds these statements from the structured XBRL data CME Group Inc. files with the SEC. It is provided for information only and is not investment advice.

Financials · CME

CME Group Inc. (CME) financials

For the twelve months ended Sep 30, 2026, CME Group Inc. reported $6.97B of revenue and $4.43B of net income.

Revenue, TTM: $6.97B
Revenue growth, YoY: +9.0%
Net income, TTM: $4.43B
Net income growth, YoY: +17.0%
Net margin: 63.5%
Free cash flow, TTM: $4.33B
EPS, diluted, TTM: $12.19
EPS growth, YoY: +18.1%
Cash: $2.20B
P/E: 24.72
P/S: 15.70
Market cap: $109.49B

Annual revenue$6.52B

FY2016FY2025

Annual net income$4.07B

FY2016FY2025

Annual free cash flow$4.19B

FY2016FY2025

CME revenue and earnings growth

CME revenueQ3 2026$1.74B

Quarter YoY: +13.0%
QoQ: +1.8%
FY YoY: +6.4%
5Y CAGR: +6.0%
10Y CAGR: +7.0%

CME revenue was $1.74B in fiscal Q3 2026 (ended Sep 30, 2026), up 13.0% from a year earlier and up 1.8% from the prior quarter. For the full fiscal 2025 it was $6.52B, up 6.4% from fiscal 2024. Compound annual growth was +6.0% over 5 years and +7.0% over 10 years. It rose in 9 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

CME net incomeQ3 2026$1.04B

Quarter YoY: +14.2%
QoQ: -0.5%
FY YoY: +15.5%
5Y CAGR: +14.1%
10Y CAGR: +12.6%

CME net income was $1.04B in fiscal Q3 2026 (ended Sep 30, 2026), up 14.2% from a year earlier and down 0.5% from the prior quarter. For the full fiscal 2025 it was $4.07B, up 15.5% from fiscal 2024. Compound annual growth was +14.1% over 5 years and +12.6% over 10 years. It rose in 8 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

CME EPSQ3 2026$2.89

Quarter YoY: +16.1%
QoQ: +0.3%
FY YoY: +15.4%
5Y CAGR: +13.7%
10Y CAGR: +11.7%

CME diluted EPS was $2.89 in fiscal Q3 2026 (ended Sep 30, 2026), up 16.1% from a year earlier and up 0.3% from the prior quarter. For the full fiscal 2025 it was $11.16, up 15.4% from fiscal 2024. Compound annual growth was +13.7% over 5 years and +11.7% over 10 years.

CME free cash flowQ3 2026$1.07B

Quarter YoY: +12.7%
QoQ: +15.9%
FY YoY: +16.6%
5Y CAGR: +10.7%
10Y CAGR: +11.5%

CME free cash flow was $1.07B in fiscal Q3 2026 (ended Sep 30, 2026), up 12.7% from a year earlier and up 15.9% from the prior quarter. For the full fiscal 2025 it was $4.19B, up 16.6% from fiscal 2024. Compound annual growth was +10.7% over 5 years and +11.5% over 10 years. It rose in 9 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

Export CSV

Income statement

Income statement
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue	$6.52B	$6.13B	$5.58B	$5.02B	$4.69B	$4.88B	$4.87B	$4.31B	$3.64B	$3.60B
Operating income	$4.23B	$3.93B	$3.44B	$3.02B	$2.65B	$2.64B	$2.59B	$2.61B	$2.31B	$2.20B
Pre-tax income	$5.33B	$4.54B	$4.15B	$3.49B	$3.37B	$2.72B	$2.69B	$2.78B	$2.53B	$2.29B
Income tax	$1.26B	$1.02B	$927.40M	$799.30M	$736.70M	$615.70M	$573.80M	$814.10M	-$1.54B	$753.50M
Net income	$4.07B	$3.53B	$3.23B	$2.69B	$2.64B	$2.11B	$2.12B	$1.96B	$4.06B	$1.53B
EPS, basic	$11.18	$9.69	$8.87	$7.41	$7.30	$5.88	$5.93	$5.73	$12.00	$4.55
EPS, diluted	$11.16	$9.67	$8.86	$7.40	$7.29	$5.87	$5.91	$5.71	$11.94	$4.53
Diluted shares	360.3M	359.9M	359.5M	359.2M	358.9M	358.5M	358.2M	343.7M	340.2M	339.0M

Balance sheet

Balance sheet
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Cash and equivalents	$4.42B	$101.79B	$2.91B	$137.97B	$160.79B	$88.42B	$38.63B	$40.83B	$1.91B	$1.96B
Short-term investments	$125.00M	$113.20M	$111.70M	$96.00M	$115.00M	$100.90M	$83.20M	$72.90M	$90.10M	$83.30M
Receivables	$639.20M	$573.10M	$535.60M	$483.20M	$434.50M	$461.30M	$491.80M	$553.30M	$359.70M	$364.40M
Current assets	$165.36B	$103.03B	$94.89B	$139.08B	$161.76B	$89.28B	$39.57B	$41.89B	$46.91B	$40.03B
Goodwill	$10.51B	$10.49B	$10.50B	$10.48B	$10.53B	$10.80B	$10.74B	$10.81B	$7.57B	$7.57B
Total assets	$198.42B	$137.45B	$129.71B	$174.18B	$196.78B	$124.66B	$75.22B	$77.48B	$75.79B	$69.37B
Current liabilities	$160.30B	$102.31B	$93.42B	$137.69B	$160.40B	$88.20B	$38.52B	$41.27B	$45.67B	$38.95B
Short-term debt	$0	$749.80M	$0	$16.00M	$749.40M	$0	$0	$574.20M	$0	-
Total liabilities	$169.70B	$110.96B	$102.97B	$147.30B	$169.38B	$98.31B	$49.06B	$51.51B	$53.38B	$49.03B
Shareholders' equity	$28.73B	$26.49B	$26.74B	$26.88B	$27.40B	$26.35B	$26.16B	$25.97B	$22.41B	$20.34B

Cash flow

Cash flow
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Operating cash flow	$4.28B	$3.69B	$3.45B	$3.06B	$2.40B	$2.72B	$2.67B	$2.44B	$1.75B	$1.73B
Capital expenditures	$83.50M	$94.00M	$76.40M	$89.70M	$127.20M	$197.50M	$245.60M	$116.70M	$81.90M	$91.80M
Free cash flow	$4.19B	$3.60B	$3.38B	$2.97B	$2.28B	$2.52B	$2.43B	$2.32B	$1.67B	$1.64B
Investing cash flow	$1.50B	-$82.60M	$20.90M	-$489.80M	$58.40M	-$175.50M	-$152.60M	-$1.89B	$179.90M	$53.70M
Financing cash flow	$56.51B	$5.08B	-$48.34B	-$25.38B	$69.91B	$47.25B	-$2.34B	-$1.08B	-$1.99B	-$1.62B
Dividends paid	$3.93B	$3.58B	$3.24B	$2.63B	$2.19B	$2.11B	$1.70B	$2.15B	$1.99B	$1.79B
Stock-based compensation	$94.80M	$89.50M	$82.90M	$84.30M	$75.20M	$96.00M	$73.10M	$96.50M	$58.00M	$66.20M
Depreciation and amortization	$107.50M	$115.10M	$126.00M	$134.90M	$147.80M	$153.20M	$158.60M	$118.70M	$113.00M	$129.20M

Key ratios

Key ratios
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue growth, YoY	6.4%	9.9%	11.1%	7.0%	-4.0%	0.3%	13.0%	18.2%	1.4%	8.1%
Net income growth, YoY	15.5%	9.3%	19.9%	2.0%	25.2%	-0.5%	7.9%	-51.7%	164.9%	23.0%
EPS growth, YoY	15.4%	9.1%	19.7%	1.5%	24.2%	-0.7%	3.5%	-52.2%	163.6%	22.8%
Operating margin	64.9%	64.1%	61.6%	60.1%	56.4%	54.0%	53.2%	60.5%	63.4%	61.2%
Net margin	62.5%	57.5%	57.8%	53.6%	56.2%	43.1%	43.5%	45.5%	111.5%	42.7%
Free cash flow margin	64.3%	58.7%	60.5%	59.1%	48.5%	51.6%	49.9%	53.9%	45.8%	45.6%
Return on equity	14.2%	13.3%	12.1%	10.0%	9.6%	8.0%	8.1%	7.6%	18.1%	7.5%
Return on assets	2.1%	2.6%	2.5%	1.5%	1.3%	1.7%	2.8%	2.5%	5.4%	2.2%
Current ratio	1.03	1.01	1.02	1.01	1.01	1.01	1.03	1.01	1.03	1.03

Income statement

Income statement
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue	$1.74B	$1.71B	$1.88B	$1.65B	$1.54B	$1.69B	$1.64B	$1.53B	$1.58B	$1.53B	$1.49B	$1.44B
Operating income	$1.14B	$1.11B	$1.31B	$1.02B	$972.60M	$1.13B	$1.11B	$947.10M	$1.02B	$1.00B	$959.60M	$863.20M
Pre-tax income	$1.35B	$1.33B	$1.51B	$1.58B	$1.18B	$1.33B	$1.24B	$1.10B	$1.18B	$1.15B	$1.11B	$1.01B
Income tax	$317.90M	$285.90M	$356.60M	$395.50M	$269.00M	$305.20M	$288.60M	$222.00M	$264.10M	$271.30M	$258.20M	$191.40M
Net income	$1.04B	$1.04B	$1.17B	$1.18B	$908.00M	$1.03B	$944.20M	$908.00M	$901.30M	$872.10M	$844.40M	$844.70M
EPS, basic	$2.90	$2.89	$3.25	$3.25	$2.49	$2.81	$2.63	$2.40	$2.51	$2.43	$2.35	$2.24
EPS, diluted	$2.89	$2.88	$3.18	$3.24	$2.49	$2.81	$2.62	$2.40	$2.50	$2.42	$2.35	$2.23
Diluted shares	358.6M	361.3M	363.2M	-	360.4M	360.4M	360.2M	-	360.0M	359.9M	359.8M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Cash and equivalents	$2.20B	$2.14B	$2.39B	$4.42B	$2.45B	$1.98B	$1.41B	$101.79B	$2.32B	$1.79B	$1.44B	$2.91B
Short-term investments	$131.00M	$131.40M	$124.20M	$125.00M	$123.20M	$117.60M	$113.90M	$113.20M	$112.30M	$121.70M	$121.00M	$111.70M
Receivables	$788.10M	$753.10M	$935.50M	$639.20M	$642.90M	$667.60M	$770.20M	$573.10M	$629.40M	$599.50M	$628.20M	$535.60M
Current assets	$159.14B	$161.63B	$169.00B	$165.36B	$152.80B	$145.45B	$123.45B	$103.03B	$103.14B	$88.75B	$97.31B	$94.89B
Goodwill	$10.51B	$10.51B	$10.51B	$10.51B	$10.51B	$10.52B	$10.50B	$10.49B	$10.51B	$10.49B	$10.49B	$10.50B
Total assets	$192.09B	$194.68B	$201.99B	$198.42B	$187.14B	$179.91B	$157.83B	$137.45B	$137.80B	$123.38B	$132.05B	$129.71B
Current liabilities	$156.11B	$158.72B	$166.00B	$160.30B	$149.59B	$142.79B	$121.42B	$102.31B	$100.82B	$86.97B	$96.10B	$93.42B
Short-term debt	-	-	-	$0	$0	$0	$0	$749.80M	$749.70M	$749.50M	$749.30M	$0
Total liabilities	$165.53B	$168.16B	$175.38B	$169.70B	$158.95B	$152.17B	$130.80B	$110.96B	$109.58B	$95.74B	$104.90B	$102.97B
Shareholders' equity	$26.56B	$26.52B	$26.62B	$28.73B	$28.19B	$27.74B	$27.03B	$26.49B	$28.22B	$27.64B	$27.15B	$26.74B

Cash flow

Cash flow
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Operating cash flow	$1.09B	$947.10M	$1.26B	$1.13B	$968.10M	$1.06B	$1.12B	$1.02B	$1.00B	$776.90M	$892.70M	$1.04B
Capital expenditures	$15.80M	$23.60M	$21.80M	$32.50M	$18.40M	$18.40M	$14.20M	$26.20M	$29.80M	$18.20M	$19.80M	$20.80M
Free cash flow	$1.07B	$923.50M	$1.24B	$1.10B	$949.70M	$1.04B	$1.10B	$991.70M	$973.20M	$758.70M	$872.90M	$1.02B
Investing cash flow	-$20.60M	-$29.40M	-$23.00M	$1.55B	-$19.10M	-$18.00M	-$16.00M	-$25.30M	-$29.50M	-$5.00M	-$22.80M	-$20.40M
Financing cash flow	-$3.94B	-$8.09B	$2.12B	$9.90B	$6.40B	$21.00B	$19.21B	-$984.10M	$13.35B	-$9.22B	$1.94B	$2.59B
Dividends paid	$464.80M	$468.10M	$2.70B	$455.00M	$455.30M	$455.30M	$2.57B	$418.80M	$418.50M	$418.50M	$2.33B	$400.10M
Stock-based compensation	$24.10M	$24.80M	$21.80M	$28.90M	$24.00M	$20.70M	$21.20M	$27.10M	$20.30M	$18.80M	$23.30M	$24.30M

Key ratios

Key ratios
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025* Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024* Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023* Dec 31, 2023
Revenue growth, YoY	13.0%	0.8%	14.5%	8.1%	-3.0%	10.4%	10.4%	6.0%	18.4%	12.7%	3.2%	19.2%
Net income growth, YoY	14.2%	1.6%	23.7%	30.3%	0.7%	17.5%	11.8%	7.5%	21.7%	13.6%	-3.2%	27.3%
EPS growth, YoY	16.1%	2.5%	21.4%	35.0%	-0.4%	16.1%	11.5%	7.6%	21.4%	13.1%	-3.3%	26.7%
Operating margin	65.7%	64.9%	69.7%	61.8%	63.3%	66.7%	67.5%	62.1%	64.6%	65.3%	64.5%	60.0%
Net margin	59.7%	61.1%	62.1%	71.7%	59.1%	60.6%	57.5%	59.5%	56.9%	56.9%	56.8%	58.7%
Free cash flow margin	61.6%	54.1%	65.9%	66.8%	61.8%	61.5%	67.1%	65.0%	61.4%	49.5%	58.7%	71.1%
Current ratio	1.02	1.02	1.02	1.03	1.02	1.02	1.02	1.01	1.02	1.02	1.01	1.02

Source: XBRL data CME Group Inc. files with the SEC, latest filing dated Oct 23, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures and share counts are restated for stock splits the filings show: 5-for-1, first reported Aug 8, 2012.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

CME peers

Company	Revenue	Growth	Net income	Net margin	Market cap
CME	$6.97B	+9.0%	$4.43B	63.5%	$109.49B
MSMorgan Stanley	$80.16B	+16.2%	$20.45B	25.5%	$284.96B
GSGoldman Sachs Group Inc.	$69.70B	+18.7%	$22.17B	31.8%	$249.73B
BLKBlackRock Inc.	$28.54B	+24.7%	$6.91B	24.2%	$182.05B
SCHWCharles Schwab Corporation	$27.06B	+18.1%	$10.64B	39.3%	$158.22B
ICEIntercontinental Exchange Inc.	$14.05B	+12.1%	$4.16B	29.6%	$96.27B
HOODRobinhood Markets Inc.	$5.08B	+20.9%	$1.98B	39.0%	$72.86B
NDAQNasdaq Inc.	$9.15B	+11.5%	$2.08B	22.8%	$59.44B
IBKRInteractive Brokers Group Inc.	$7.12B	+19.7%	$1.18B	16.5%	$34.35B

CME FAQ

8 questions

What is CME revenue?
CME Group Inc. (CME) reported $6.97B of revenue for the twelve months ended Sep 30, 2026. That is up 9.0% from the year before. Revenue for fiscal 2025 was $6.52B.
Is CME profitable?
Yes. CME Group Inc. earned $4.43B in net income for the twelve months ended Sep 30, 2026, a net margin of 63.5%.
How much cash and debt does CME have?
CME Group Inc. reported $2.20B in cash and cash equivalents on its most recent balance sheet in SEC filings.
How fast is CME revenue growing?
CME Group Inc.'s revenue changed +6.4% in fiscal 2025, to $6.52B. Its compound annual growth rate was +6.0% over 5 years and +7.0% over 10 years.
What is CME free cash flow?
CME Group Inc. generated $4.33B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $4.43B less capital expenditures.
What is CME earnings per share?
Diluted earnings per share were $12.19 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did CME last report financial results?
The latest statements here come from CME Group Inc.'s 10-Q filed on Oct 23, 2026, covering the period ended Sep 30, 2026.
Where does this CME financial data come from?
Quantisnow builds these statements from the structured XBRL data CME Group Inc. files with the SEC. It is provided for information only and is not investment advice.